Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Vagal Nerve Stimulation (VNS) Market 2022
Vagus nerve stimulation (VNS) involves the use of a device to stimulate the vagus nerve with electrical impulses. VNS may be an option to reduce the frequency of seizures in people who haven’t achieved control with medications. Vagus nerve stimulation may also be helpful for people who haven’t responded to intensive depression treatments, such as antidepressant medications, psychological counseling (psychotherapy) and electroconvulsive therapy (ECT). The global vagal nerve stimulation market is poised to grow by US$ 420.5 million during 2022-2028, progressing at a CAGR of 9.8% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for vagal nerve stimulation. The global vagal nerve stimulation market is segmented on the basis of product, application, end user, and region. By product, the global vagal nerve stimulation market has been segmented into external VNS devices, implantable VNS devices. In 2021, the implantable VNS devices segment made up the largest share of revenue generated by the vagal nerve stimulation market. Based upon application, the global vagal nerve stimulation market is categorized into depression, epilepsy, others. The epilepsy segment was the largest contributor to the global vagal nerve stimulation market in 2021. On the basis of end user, the global vagal nerve stimulation market has been segmented into ambulatory surgical centers (ASCs), hospitals, others. Geographically, the global vagal nerve stimulation market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).
The diagnosis market is further segmented into computed tomography (CT), magnetic Resonance Imaging (MRI), and others. Among these, the CT segment was accounted for the highest revenue generator in 2021. Furthermore, the treatment market has been categorized into medication, and surgery. The medication segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period.
The global vagal nerve stimulation market is highly competitive. The leading players in the vagal nerve stimulation market include Boston Scientific Corporation, electroCore Inc., ImThera Medical Inc. (LivaNova PLC), Innovative Health Solutions Inc, Inspire Medical Systems Inc, NeuroMetrix Inc., Parasym Ltd, ReShape Lifesciences Inc.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the vagal nerve stimulation market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Product: external VNS devices, implantable VNS devices
Application: depression, epilepsy, others
End user: ambulatory surgical centers (ASCs), hospitals, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028
Key Benefits for Stakeholders
– Get a comprehensive picture of the global vagal nerve stimulation market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Vagal nerve stimulation market overview
Part 3. Market breakdown by product
– External VNS devices
– Implantable VNS devices
Part 4. Market breakdown by application
Part 5. Market breakdown by end user
– Ambulatory surgical centers (ASCs)
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Rest of the World (ROW)
Part 7. Key companies
– Boston Scientific Corporation
– electroCore, Inc.
– ImThera Medical, Inc. (LivaNova PLC)
– Innovative Health Solutions, Inc
– Inspire Medical Systems Inc
– NeuroMetrix, Inc.
– Parasym Ltd
– ReShape Lifesciences Inc.